Glaxosmithkline Consumer Healthcare Ltd. [Merged]

₹10,732.60

up-down-arrow496.30 (4.85%)

As on 15-Apr-2020IST

Market cap

info icon

₹45,225 Cr

Revenue (TTM)

info icon

₹4,984 Cr

P/E Ratio

info icon

39.1

P/B Ratio

info icon

10.2

Div. Yield

info icon

1 %

Glaxosmithkline [Merged] Share Price

Compare

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 10,310.00 High: 10,850.00

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹622 Cr

  • ROEROE information

    25.9 %

  • ROCEROCE information

    39.9 %

  • Industry P/EIndustry P/E information

    25.12

  • EV/EBITDAEV/EBITDA information

    24

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹--

  • EPSEPS information

    ₹274.8

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    42,055,538

10 Years Aggregate

CFO

₹5,497.78 Cr

EBITDA

₹7,068.81 Cr

Net Profit

₹5,609.81 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Glaxosmithkline [Merged]
29.2 21.5 23.0 49.0 26.5 11.3 21.5
BSE Sensex*
-9.2 4.5 -6.1 -2.9 8.2 9.5 11.4
BSE FMCG#
-6.7 10.0 0.5 -8.4 3.3 8.3 9.1
As on 15-Apr-2020  |  *As on 28-Apr-2026  |  #As on 28-Apr-2026
Company
2019
2018
2017
2016
2015
2014
Glaxosmithkline [Merged]
9.7 18.0 30.7 -21.4 9.9 32.6
BSE Sensex
14.4 5.9 27.9 1.9 -5.0 29.9
BSE FMCG
-3.6 10.5 31.5 3.3 1.4 18.3

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Glaxosmithkline [Merged]
10,732.6 45,225.1 4,984.3 1,155.8 23.9 28 39.1 10.2
1,146.9 6,902.1 3,960.4 265.2 6.6 18.5 26 4.3
969.7 21,720.2 9,624.4 348.3 6.4 19.6 62.4 11.5
7.6 37.7 171.9 3.3 -- 10.6 11.6 0.6
364.7 3,391.7 4,416.9 167.1 4.9 16.2 20.6 3.1
38.0 110.8 338.8 22.4 1.9 55.1 4.9 1.9
230.2 2,876.9 3,790.4 129.0 5.0 12.1 22.3 2.3
353.2 376.9 326.2 15.7 11.6 11.7 24 2.7
4,757.1 3,437.9 1,359.7 122.3 11.4 16.5 28.1 4.8
39.1 84.5 167.2 -7.2 -3.9 -10.9 -- 1.4

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

About Glaxosmithkline [Merged]

Manufacture of malted foods including foods for infants and handicapped

  • Incorporated

    1958

  • Chairman

    P Dwarakanath

  • Managing Director

    Navneet Saluja

  • Group

    Glaxosmithkline - MNC

  • Headquarters

    Nabha, Punjab

  • Website

    http://www.gsk-ch.in/

Edit peer-selector-edit
loading...
loading...

FAQs for Glaxosmithkline [Merged]

The share price of Glaxosmithkline Consumer Healthcare Ltd [Merged] is ₹10,732.60 (NSE) and ₹10,753.65 (BSE) as of 15-Apr-2020 IST. Glaxosmithkline Consumer Healthcare Ltd [Merged] has given a return of 26.53% in the last 3 years.

The P/E ratio of Glaxosmithkline Consumer Healthcare Ltd [Merged] is 39.13 times as on 15-Apr-2020, a 56 premium to its peers’ median range of 25.12 times.
The P/B ratio of Glaxosmithkline Consumer Healthcare Ltd [Merged] is 10.19 times as on 15-Apr-2020, a 145 premium to its peers’ median range of 4.16 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2019
30.86
7.41
2018
36.61
7.36
2017
33.04
6.95
2016
36.93
9.07
2015
45.40
12.54

The 52-week high and low of Glaxosmithkline Consumer Healthcare Ltd [Merged] are Rs -- and Rs -- as of 28-Apr-2026.

Glaxosmithkline Consumer Healthcare Ltd [Merged] has a market capitalisation of ₹ 45,225 Cr as on 15-Apr-2020. As per SEBI classification, it is a company.

Before investing in Glaxosmithkline Consumer Healthcare Ltd [Merged], assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.